239
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Pharmacophore model and atom-based 3D quantitative structure activity relationship (QSAR) of human immunodeficiency virus-1 (HIV-1) capsid assembly inhibitors

, , , &
Pages 718-727 | Received 16 Sep 2019, Accepted 03 Jan 2020, Published online: 25 Jan 2020

References

  • Agosto, L. M., Zhong, P., Munro, J., & Mothes, W. (2014). Highly active antiretroviral therapies are effective against HIV-1 cell-to-cell transmission. PLoS Pathogens, 10(2), e1003982. doi:10.1371/journal.ppat.1003982
  • Barrera, F. N., Hurtado-Gómez, E., Lidón-Moya, M. C., & Neira, J. L. (2006). Binding of the C-terminal domain of the HIV-1 capsid protein to lipid membranes: A biophysical characterization. Biochemical Journal, 394(1), 345–353. doi:10.1042/BJ20051487
  • Bhole, R. P., & Bhusari, K. P. (2009). Synthesis, antimycobacterial activity and 3‐D QSAR studies of some new derivatives of p‐hydroxybenzohydrazide. QSAR & Combinatorial Science, 28(11–12), 1405–1417. doi:10.1002/qsar.200960064
  • Bhole, R. P., & Bhusari, K. P. (2011). Synthesis, antihypertensive activity, and 3D‐QSAR studies of some new p‐hydroxybenzohydrazide derivatives. Archiv der Pharmazie, 344(2), 119–134. doi:10.1002/ardp.201000008
  • Bhole, R. P., Bonde, C. G., & Zambare, Y. B. (2018). Effective potential studies for some new hybrid molecules for their activity against prostate cancer. Ars Pharmaceutica, 59 (3), 1–12.
  • Bhole, R. P., Bonde, C. G., & Zambare, Y. B. (2019). Synthesis and evaluation of novel N‐cycloheptyl‐substituted ‐2,3‐ dihydro‐1,3‐benzothiazole‐2‐carboxamide targeting the estrogen binding receptor. Jordan Journal of Pharmaceutical Sciences, 12(3), 1–10.
  • Bhowmick, S., Chorge, R. D., Jangam, C. S., Bharatrao, L. D., Patil, P. C., Chikhale, R. V., & Islam, M. A. (2019). Identification of potential cruzain inhibitors using de novo design, molecular docking and dynamics simulations studies. Journal of Biomolecular Structure and Dynamics, 1–11. doi:10.1080/07391102.2019.1664334
  • Cerutti, D., Cheatham, T. III, Darden, T., Duke, R., Giese, T., Gohlke, H., & Janowski, P. (2016). AMBER 2016. San Francisco: University of California.
  • Chirico, N., & Gramatica, P. (2011). Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient. Journal of chemical information and Modeling, 51(9), 2320–2335. doi:10.1021/ci200211n
  • Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of computer-aided molecular Design, 20(10-11), 647–671. doi:10.1007/s10822-006-9087-6
  • Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology Drug Design, 67(5), 370–372. doi:10.1111/j.1747-0285.2006.00384.x
  • Fader, L. D., Bethell, R., Bonneau, P., Bös, M., Bousquet, Y., Cordingley, M. G., & Gagnon, A. (2011). Discovery of a 1, 5-dihydrobenzo [b][1, 4] diazepine-2, 4-dione series of inhibitors of HIV-1 capsid assembly. Bioorganic & Medicinal Chemistry Letters, 21(1), 398–404. doi:10.1016/j.bmcl.2010.10.131
  • Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. doi:10.1517/17460441.2015.1032936
  • Jangam, C. S., Bhowmick, S., Chorge, R. D., Bharatrao, L. D., Patil, P. C., Chikhale, R. V., … Islam, M. A. (2019). Pharmacoinformatics-based identification of anti-bacterial catalase-peroxidase enzyme inhibitors. Computational Biology and Chemistry, 83, 107136. doi:10.1016/j.compbiolchem.2019.107136
  • Lemke, C. T., Titolo, S., von Schwedler, U., Goudreau, N., Mercier, J.-F., Wardrop, E., … Mason, S. W. (2012). Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. Journal of Virology, 86(12), 6643–6655. doi:10.1128/JVI.00493-12
  • Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. doi:10.1021/acs.jctc.5b00255
  • McColl, D. J., & Chen, X. (2010). Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy. Antiviral Research, 85(1), 101–118. doi:10.1016/j.antiviral.2009.11.004
  • Peramo, A. (2016). Solvated and generalised Born calculations differences using GPU CUDA and multi-CPU simulations of an antifreeze protein with AMBER. Molecular Simulation, 42(15), 1263–1273. doi:10.1080/08927022.2016.1183000
  • Roe, D. R., & Cheatham, T. E. III. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. doi:10.1021/ct400341p
  • Tilton, J. C., & Doms, R. W. (2010). Entry inhibitors in the treatment of HIV-1 infection. Antiviral Research, 85(1), 91–100. doi:10.1016/j.antiviral.2009.07.022
  • Vogt, V. (1996). Proteolytic processing and particle maturation. In Morphogenesis and maturation of retroviruses. (pp. 95–131). Berlin: Springer.
  • Yamashita, M., Perez, O., Hope, T. J., & Emerman, M. (2007). Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathogens, 3(10), e156. doi:10.1371/journal.ppat.0030156

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.